These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 28585071

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.
    Eur J Haematol; 2010 Jan 01; 84(1):72-8. PubMed ID: 19732137
    [Abstract] [Full Text] [Related]

  • 44. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
    Altès A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E.
    Bone Marrow Transplant; 2002 Jun 01; 29(12):987-9. PubMed ID: 12098067
    [Abstract] [Full Text] [Related]

  • 45. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
    Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, Hagihara M, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H.
    Int J Hematol; 2011 Mar 01; 93(3):368-374. PubMed ID: 21331523
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
    Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC.
    Anal Biochem; 1999 Sep 10; 273(2):212-20. PubMed ID: 10469492
    [Abstract] [Full Text] [Related]

  • 48. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry.
    Jakeman A, Thompson T, McHattie J, Lehotay DC.
    Clin Biochem; 2001 Feb 10; 34(1):43-7. PubMed ID: 11239514
    [Abstract] [Full Text] [Related]

  • 49. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.
    Panch SR, Yau YY, West K, Diggs K, Sweigart T, Leitman SF.
    Transfusion; 2015 Mar 10; 55(3):611-22. PubMed ID: 25209879
    [Abstract] [Full Text] [Related]

  • 50. The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload.
    Sivgin S, Karamustafaoglu MF, Yildizhan E, Zararsiz G, Kaynar L, Eser B, Cetin M, Unal A.
    Clin Lymphoma Myeloma Leuk; 2016 Aug 10; 16 Suppl():S152-8. PubMed ID: 27521313
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar 10; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 53. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR, Kim JS, Cheong JW, Song JW, Min YH.
    Acta Haematol; 2008 Mar 10; 120(3):182-9. PubMed ID: 19129689
    [Abstract] [Full Text] [Related]

  • 54. An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in β-thalassemia major patients: A double-blind randomized controlled clinical trial.
    Mohammadi E, Tamaddoni A, Qujeq D, Nasseri E, Zayeri F, Zand H, Gholami M, Mir SM.
    Phytother Res; 2018 Sep 10; 32(9):1828-1835. PubMed ID: 29806132
    [Abstract] [Full Text] [Related]

  • 55. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Sweetenham J, Kalaycio M, Copelan E.
    Br J Haematol; 2009 Aug 10; 146(3):310-6. PubMed ID: 19508292
    [Abstract] [Full Text] [Related]

  • 56. Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways.
    Garbowski MW, Bansal S, Porter JB, Mori C, Burckhardt S, Hider RC.
    Haematologica; 2021 Nov 01; 106(11):2885-2896. PubMed ID: 33054113
    [Abstract] [Full Text] [Related]

  • 57. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.
    Akı SZ, Paşaoğlu H, Yeğin ZA, Suyanı E, Demirtaş CY, Ozkurt ZN, Yağcı M, Sucak GT.
    Hematology; 2011 Sep 01; 16(5):284-90. PubMed ID: 21902892
    [Abstract] [Full Text] [Related]

  • 58. [Non-transferrin-bound iron: a promising biomarker in iron overload disorders].
    Maas RP, Voets PJ, de Swart L, Swinkels DW.
    Ned Tijdschr Geneeskd; 2013 Sep 01; 157(49):A6258. PubMed ID: 24299624
    [Abstract] [Full Text] [Related]

  • 59. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
    Majhail NS, Lazarus HM, Burns LJ.
    Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):832-7. PubMed ID: 20079863
    [Abstract] [Full Text] [Related]

  • 60. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis.
    Bruns T, Nuraldeen R, Mai M, Stengel S, Zimmermann HW, Yagmur E, Trautwein C, Stallmach A, Strnad P.
    Liver Int; 2017 Feb 01; 37(2):232-241. PubMed ID: 27473364
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.